mg56
Biologicalexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 30, 2015 (NCT02654223)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mg56
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02654223 | Phase 2 | Dec 30, 2015 | Hospital Universitario Getafe, Hospital Universitario Infanta Elena, Inmunotek S.L., Universidad Autonoma de Madrid, Universidad Complutense de Madrid |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hospital Universitario Getafe | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Hospital Universitario Infanta Elena | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Inmunotek S.L. | For profit | 1 | 1 | 1 | 2015 |
| Universidad Autonoma de Madrid | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Universidad Complutense de Madrid | Academic/Hospital | 1 | 0 | 1 | 2015 |
5 organizations
Page 1 / 1